Oncolys BioPharma Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was JPY 63.04 million compared to JPY 976.18 million a year ago. Net loss was JPY 1,938.51 million compared to JPY 1,148.94 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
710 JPY | +2.16% | -0.98% | +25.22% |
1st Jan change | Capi. | |
---|---|---|
+25.22% | 92.13M | |
-4.24% | 86.85B | |
+2.76% | 40.16B | |
-16.48% | 31.28B | |
+57.86% | 25.27B | |
-13.58% | 15.33B | |
-9.12% | 11.96B | |
-42.56% | 11.61B | |
+6.89% | 8.83B | |
-10.53% | 7.94B |
- Stock Market
- Equities
- 4588 Stock
- News Oncolys BioPharma Inc.
- Oncolys BioPharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2023